about
Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer ProgressionRadiological and Clinical Features associated with Epidermal Growth Factor Receptor Mutation Status of Exon 19 and 21 in Lung AdenocarcinomaA bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancerA prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer.Ligation of CM1 enhances apoptosis of lung cancer cells through different mechanisms in conformity with EGFR mutationLower limb lymphedema in lung adenocarcinoma: Two case reports.Bevacizumab treatment for advanced non-small cell lung cancer: A case report.Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experiencePalliative sequential chemoradiotherapy for pulmonary sulcus tumor: A case report.In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells.Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking statusExpression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancerCD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells.Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy.Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas.High performance liquid chromatography: Tandem mass spectrometric determination of cisplatin levels in different visceral pleura layers of rats.DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.Risk of rash associated with vandetanib treatment in non-small-cell lung cancer patients: A meta-analysis of 9 randomized controlled trials.Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma.Prognostic Value of Tumor-to-Blood Standardized Uptake Ratio in Patients with Resectable Non-Small-Cell Lung Cancer.[Analysis of prognostic factors in patients with stage IV lung adenocarcinoma after failure of second-line EGFR-TKIs therapy].[The targets research of non-small cell lung cancer targeted therapy].Score for lung adenocarcinoma in China with EGFR mutation of exon 19: Combination of clinical and radiological characteristics analysis
P2860
Q33588186-FD147B40-451B-4D46-824A-4A1B06228F51Q33673131-649C621C-0A9A-4E20-8313-F897937DE312Q33689021-053BDC70-F12C-400C-87D6-4077571C5C23Q34041754-7243360E-18C2-4810-A27E-8FA277CDAF6CQ35106391-0BBFD2DC-9E7F-4408-9FD7-D11A2D93A71EQ36524382-7814E323-012D-40AE-9935-DC4BB95035E6Q36642944-37CADE6F-9B6F-4A48-B263-7063E4205622Q37288457-C3D2E1A0-CBC5-4808-899D-58ACB07C244EQ37326156-02214864-FF70-41C0-BECB-6B2A03C8A404Q37372172-64621E1C-EF47-436D-A7D6-2ADAB281B781Q37406810-ABFF7445-FD66-4A18-8F1E-568A7B36867FQ37418236-73B45A79-FABA-4C84-9B87-EDD14B766247Q37564820-B2D56A69-6B67-4A26-9A84-034B9E6281BEQ37636614-C96D246E-2E0D-46B6-BF8F-E401803E5ECBQ37701272-70899594-F5AC-436B-8F56-425A81A8FFE1Q37737009-7DE92470-2631-4ED7-8331-8B1485682286Q39467892-8359EC69-E2F4-4220-8B80-2664E47907F1Q40773994-DB33C028-CB04-4675-A725-A4C0C435356BQ41241158-05B84C1C-253C-40CA-8249-789E4CD1299CQ47128966-96B4AA6D-ABE0-4442-8874-73D2036B6432Q50192132-757A2042-2E71-43B9-8BFE-EAFB41ACC843Q50211377-0BE10588-79F9-43DA-8D0B-1C510829CA69Q54456532-01E78A96-1BD0-416F-8951-695BA9ADEDFEQ55434033-FECF958C-ED16-42A3-BE95-6528AD9F66F7Q58704176-7B1B9FA7-5389-42CE-B693-882533C654AA
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Treatment of advanced non small cell lung cancer.
@ast
Treatment of advanced non small cell lung cancer.
@en
type
label
Treatment of advanced non small cell lung cancer.
@ast
Treatment of advanced non small cell lung cancer.
@en
prefLabel
Treatment of advanced non small cell lung cancer.
@ast
Treatment of advanced non small cell lung cancer.
@en
P2093
P2860
P1476
Treatment of advanced non small cell lung cancer.
@en
P2093
Antonio Rossi
Clorinda Schettino
Maria Anna Bareschino
Paola Claudia Sacco
Paolo Maione
Rosario Zeppa
P2860
P304
P356
10.3978/J.ISSN.2072-1439.2010.12.08
P577
2011-06-01T00:00:00Z